Naprosyn (Naproxen)

Naproxen blocks the cyclooxygenase (COX) enzymes that produce prostaglandins, which are mediators of inflammation and pain. By lowering prostaglandin levels in the tissue where it is applied, naproxen reduces the inflammatory response and the perception of pain.

The specific dose and frequency of Naprosyn are determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and the product label for proper use.

Safety data for topical naproxen in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Naprosyn.

To order Naprosyn, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naprosyn contains naproxen, which has a longer half‑life than some other topical NSAIDs such as ibuprofen or diclofenac. This can allow less frequent application while providing comparable anti‑inflammatory and analgesic effects. Choice of product often depends on clinician preference, patient tolerance, and specific formulation characteristics.

Naprosyn should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain stability and efficacy.

Naprosyn is applied topically to clean, dry, intact skin over the painful area. A thin layer is spread gently and rubbed in until absorbed. The treated area should not be covered with an occlusive dressing unless directed by a healthcare professional.

Serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, cardiovascular events (e.g., heart attack), gastrointestinal bleeding or ulceration, and liver enzyme abnormalities. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with a known hypersensitivity to naproxen, other NSAIDs, or any component of the formulation should avoid Naprosyn. It is also contraindicated in patients with active gastrointestinal bleeding, severe heart failure, or those taking anticoagulants without medical supervision.